Loading
A phase 1 trial of KAN-004 run by Centre hospitalier de l'Université de Montréal (CHUM), now recruiting.
KAN-004 for Immune-Related Diarrhea or Colitis is a phase 1 interventional study registered as NCT07196410 by Centre hospitalier de l'Université de Montréal (CHUM), with 21 participants planned, started 2026-03-01. Conditions recorded: Colitis and Diarrhea Caused by Antitumor Drugs. Interventions recorded: KAN-004.
Shares Kanvas Biosciences and the tag pipeline.
Shares Kanvas Biosciences and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/